Core Viewpoint - The article highlights the innovative transformation of fish by-products into high-value bioactive peptides by Hainan Huayan, showcasing the company's commitment to research and development in the collagen peptide industry [17][18][19]. Company Overview - Hainan Huayan focuses on the deep processing of fish by-products, converting low-value materials like fish scales and skins into high-value bioactive peptide products through over 20 processing steps [17][18]. - The company provides one-stop OEM/ODM services for global brand owners, exporting products to over 50 countries and regions, including Japan and South Korea [17][18]. Research and Development - Hainan Huayan has invested significantly in R&D, dedicating 8% to 10% of its annual revenue to research, and has established partnerships with over ten research institutions [21][23]. - The company has developed a series of proprietary technologies and automated production equipment, enabling it to achieve breakthroughs in the collagen peptide sector [21][22]. Product Innovation - The flagship product, collagen peptide cyclic dipeptide, was developed after thousands of experiments, marking a significant achievement in the field and leading to the acquisition of relevant national patents [19][20]. - Hainan Huayan has successfully created a complete product system with over 120 patents and 40 enterprise standards, ensuring high product quality that competes with international counterparts [23]. Market Expansion - The company has invested nearly 200 million yuan in building a collagen peptide industrialization base, which includes two production lines with an annual capacity of 4,500 tons [25]. - Hainan Huayan aims to leverage the advantages of the Hainan Free Trade Port to explore larger market opportunities, with a reported nearly 100% growth in overseas sales in the first half of the year [26][27].

Group 1: Company Overview - Xinbao Co., Ltd. is a leading manufacturer of small household appliances, producing approximately 13% of China's export electric kettles and holding the top sales position in several niche categories globally [6][10] - In 2024, Xinbao plans to export over 12 million small appliances monthly, with annual overseas revenue exceeding 13 billion yuan [6][10] Group 2: Historical Development - Founded in 1995, Xinbao initially focused on foreign trade, with its first export order for electric irons in 1992 marking a significant turning point [8][9] - The company expanded its operations by establishing overseas marketing agencies and gradually moved from low-end orders to higher-value contracts [9] Group 3: Strategic Evolution - Following China's accession to the WTO in 2001, Xinbao experienced explosive growth, with sales increasing from 1 billion yuan in 2002 to 3 billion yuan in 2005 [9] - The company began to build its own supply chain by establishing factories for molds, plastics, and metal components, achieving over 75% self-supply rate for its electric kettles [9][10] Group 4: Brand Development - Xinbao launched its own brand "Dongling" in 2003 but faced challenges in the domestic market, leading to a focus on partnerships with established brands like Morphy Richards in 2015 [11][12] - The company has transitioned from an Original Equipment Manufacturer (OEM) to an Original Design Manufacturer (ODM), with ODM products now accounting for 50% of its output [12] Group 5: International Expansion - Xinbao has established production capabilities in Indonesia, with plans to achieve sales of approximately 670 million yuan in 2024 [13] - The company emphasizes a strategy of "capacity going abroad," focusing on practical and innovative approaches to expand its international footprint [13] Group 6: Technological Innovation - Xinbao has invested over 1 billion yuan in digital manufacturing technologies, enhancing its production efficiency and responsiveness to customer demands [9][10] Group 7: Industry Context - The small household appliance industry is increasingly competitive, with a consensus among manufacturers that international expansion is essential for survival [7][9] Group 8: Company Overview (Hainan Huayan) - Hainan Huayan focuses on the deep processing of fish by-products, transforming them into high-value bioactive peptides through advanced production techniques [22][23] - The company has invested nearly 200 million yuan in a production base capable of producing 4,500 tons of fish collagen peptides annually [29] Group 9: Research and Development - Hainan Huayan allocates 8% to 10% of its annual revenue to research and development, collaborating with multiple research institutions to enhance its product offerings [26][27] - The company has developed over 120 patents and established a comprehensive product system, achieving quality parity with international competitors [27] Group 10: Market Strategy - Hainan Huayan aims to leverage the advantages of the Hainan Free Trade Port to expand its international market presence, with overseas sales increasing by nearly 100% in the first half of the year [31]

Core Viewpoint - The company, Hainan Huayan Collagen Technology Co., Ltd., has developed a method to utilize fish processing by-products, such as fish scales and skins, to produce high-value collagen peptides through enzymatic hydrolysis technology, addressing resource waste and environmental pressure in the seafood processing industry [1][2]. Group 1: Company Development and Innovation - The company has been focused on the development and utilization of marine biological resources for 20 years, achieving significant technological breakthroughs and international expansion, with products sold in over 50 countries [1][2]. - Hainan Huayan has established a world-leading marine biological peptide innovation base and has been recognized as a national high-tech enterprise [1][2]. - The company has invested 8% to 10% of its annual revenue into research and development, emphasizing the importance of enhancing its innovation capabilities for sustainable growth [5]. Group 2: Technological Advancements - The company has successfully developed a core technology for controlling biological active enzymes, which is crucial for extracting specific molecular weight peptide products [3]. - After two and a half years of research and nearly 3,000 experiments, the company achieved a breakthrough in producing a new product, cyclic dipeptide, and obtained two national patents [3]. - Collaborative research with various scientific institutions has led to significant improvements in extraction rates and product purity, achieving internationally leading technology levels [4][5]. Group 3: Market Expansion - Hainan Huayan is strategically expanding its production capacity and market presence, with plans to establish production bases in multiple locations, including Hainan and Henan, and sales centers in major cities [6]. - The company has invested in a fish collagen peptide industrialization base in Haikou, which is now the largest facility for producing marine biological peptide monomers in Asia, with an annual production capacity of 4,500 tons [6]. - A joint venture has been established in Thailand to operate a tuna peptide processing plant, marking an important step in the company's international development [6]. Group 4: Future Goals - The company aims to continuously focus on high-value utilization of marine biological resources, functional product technology research, and international market expansion, with a goal to launch 2 to 3 innovative products annually and become a leading platform for functional peptide raw material research and manufacturing by 2027 [7].

Core Viewpoint - The implementation of the Private Economy Promotion Law provides a legal foundation for the sustainable and healthy development of private enterprises in China, instilling confidence in companies like Hainan Huayan [1][2]. Group 1: Legal Framework and Support - The Private Economy Promotion Law, effective from May 20, 2025, is the first fundamental law specifically aimed at promoting the development of the private economy in China [1]. - The law establishes a principle of "equal participation," which is crucial for innovative private enterprises seeking legal protection [1][2]. - It introduces a nationwide negative list system for market access, allowing various economic organizations, including private enterprises, to enter fields outside the list on an equal legal basis [3]. Group 2: Challenges and Opportunities - Despite facing challenges such as trade barriers and financing difficulties, private high-tech enterprises like Huawei and Yushutech demonstrate resilience and vitality through innovation [2]. - The law addresses issues such as market entry barriers, financing difficulties, and disadvantages in participating in research projects, which have historically hindered the growth of private enterprises [2][3]. Group 3: Financial Support and Innovation - The law mandates financial institutions to develop financial products tailored to the characteristics of private enterprises, enhancing credit supply and improving access to financing [4]. - It emphasizes the importance of intellectual property pledge financing, allowing private enterprises to secure funding for research and innovation [4]. - Hainan Huayan has successfully launched innovative products, such as collagen peptides, which have significantly increased revenue, showcasing the potential for growth through innovation [3][4]. Group 4: Market Dynamics and Competitive Strategies - The concept of "involution" in the market is addressed, with the company advocating for healthy competition that stimulates market vitality rather than destructive price wars [5]. - Hainan Huayan is exploring new applications for its products, expanding beyond traditional markets to include sports nutrition and health products for the elderly, thereby creating new market opportunities [5]. - The law's implementation is seen as a catalyst for private enterprises to leverage technological innovation and a legal business environment to ascend the value chain [5].

央视网消息：鱼鳞、鱼皮，这些鱼身上的边角料能做什么用？在海南，有家企业敢为人先，创新性将这些边角料"变废为宝"，产品获得50 多个国家和地区市场的欢迎，成为海南海洋经济新赛道上的重要一员。 海南华研胶原科技股份有限公司，一家专注于海洋生物健康食品研发的国家级高新技术企业。这批刚到货的鱼鳞正在被清洗，在这里，它们将 通过物料运输管道开启"变身"之路。 企业负责人赵子方介绍，他们正在以鱼鳞和鱼皮为原料，生产他们的"拳头产品"——胶原蛋白环二肽。海南华研从事生物健康食品生产已经有 20年了，以前他们生产的相关保健品产品附加值低、同质化严重。近几年，他们在市场调研过程中发现，老年人对胶原蛋白环二肽的需求非常 大，而这个市场还是个空白。 赵子方介绍，他们找到了国外文献里面对环二肽的一些报道，环二肽在国外会作为一种化学合成药物来预防老年痴呆。他们想在银发经济，中 老年功能性食品上做一些布局。 通过查阅国外的资料他们发现，国外学者10年前就尝试过利用胶原蛋白肽来制取环二肽，但是获得率仅为千分之几，因为难度太大，最终没有 做出产品，不了了之。现在，一家中国的民营企业想干同样的事，能在全世界率先实现突破吗？ 当时，海南华研不仅 ...